Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer

Author： Allin Kristine H. Nordestgaard Børge G.

ISSN： 1040-8363

Source： Critical Reviews in Clinical Laboratory Sciences, Vol.48, Iss.4, 2011-08, pp. : 155-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated C‐Reactive Protein in Older People

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 40, Iss. 1, 1992-01 ,pp. : 104-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-Malignant Drivers of Elevated C-Reactive Protein Levels Differ in Patients With and Without a History of Cancer

By Johnson Timothy V. Master Viraj A.

Molecular Diagnosis & Therapy, Vol. 14, Iss. 5, 2010-10 ,pp. : 295-303

Adis International

Access to resources Recommend Favorite

The role of C‐reactive protein in prostate cancer

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3262-3264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated serum C‐reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non‐small cell lung cancer

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : e22-e30

John Wiley & Sons Inc

Access to resources Recommend Favorite

C‐reactive protein and ageing

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 44, Iss. S1, 2017-12 ,pp. : 9-14

John Wiley & Sons Inc

Access to resources Recommend Favorite